First human doses given for new inflammation pill
NCT ID NCT07029568
Summary
This was the first study in humans to test the safety of a new oral medicine called NNC0705-0001. The medicine is being developed to treat chronic inflammation, which increases the risk of heart and kidney disease. The study involved 116 healthy adults to see how safe the drug is, how the body processes it, and how it affects its target.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON - location Groningen
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.